Alexander Hillisch

Head of Global Computational Drug Design

UCB

Emilie Louvet

Clinical Information Science Director

AstraZeneca

I lead the Early oncology and NLP Oncology Information Practice team. The team deliver competitive intelligence data to enable Early Oncology Portfolio progression and drug development milestones investments decisions from Candidate Drug to Ph3ID, clinical design and clinical development plans via NLP& AI.

Cathrin Pautsch

Senior Scientist Data & Analytics

Roche

Cathrin strives to catalyze digitalization at Roche to accelerate data-driven drug discovery. She is the product owner of a synthesis planning automation (SPA) platform that leverages machine learning for predicting new synthetic routes for chemical compounds.

Andrew Buchanan

Principal Scientist (ML/Biologics)

AstraZeneca

An experienced team leader and inspiring scientist with an excellent track record of leading innovative drug discovery projects and related technologies. As a leader, member or mentor of teams Andrew has delivered more than 20 CD’s of which three are launched products benefiting patients. Andrew have over 20 years of successful cross-functional and global matrix-team leadership across BioPharm (R&I, CVRM, Neuro, ID) and Onc. With colleagues he has published over 35 original manuscripts and patents.

 

Giovanna Lalli

Director of Scientific Affairs

UK Dementia Research Institute HQ

Clay Schwabe

VP, Business Development

Pria Healthcare